🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines
Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
84 of 10,336 medicines
Download
Medicine
Active substance
Licence holder
Status
Propofol 10 mg/ml Emulsion for injection/infusion PA2299/038/001
Propofol
Baxter Holding B.V.
Marketed
Propofol 20 mg/ml Emulsion for injection/infusion PA2299/038/002
Propofol
Baxter Holding B.V.
Marketed
Ringer’s Solution for Infusion, Viaflo container PA2299/011/001
Sodium chloride, Potassium chloride, Calcium chloride dihydrate
Baxter Holding B.V.
Marketed
RIXUBIS 1000 IU powder and solvent for solution for injection EU/1/14/970/003
Nonacog gamma
Baxter Innovations GmbH
—
RIXUBIS 2000 IU powder and solvent for solution for injection EU/1/14/970/004
Nonacog gamma
Baxter Innovations GmbH
—
RIXUBIS 250 IU powder and solvent for solution for injection EU/1/14/970/001
Nonacog gamma
Baxter Innovations GmbH
—
RIXUBIS 3000 IU powder and solvent for solution for injection EU/1/14/970/005
Nonacog gamma
Baxter Innovations GmbH
—
RIXUBIS 500 IU powder and solvent for solution for injection EU/1/14/970/002
Nonacog gamma
Baxter Innovations GmbH
—
Sevoflurane Baxter, 100%, inhalation vapour, liquid PA2299/031/001
Sevoflurane
Baxter Holding B.V.
Marketed
Sodium Chloride 0.18% w/v and Glucose 4.0% w/v Intravenous Infusion BP, (Viaflo Container) PA2299/008/005
Sodium chloride, Anhydrous glucose
Baxter Holding B.V.
Marketed
Sodium Chloride 0.3% w/v and Glucose 3.3% w/v Solution for Infusion BP PA2299/008/004
Sodium chloride, Glucose
Baxter Holding B.V.
Marketed
Sodium Chloride 0.45% w/v and Glucose 2.5% w/v Solution for Infusion BP PA2299/008/003
Sodium chloride, Glucose
Baxter Holding B.V.
Marketed
Sodium Chloride 0.45% w/v and Glucose 5.0% w/v Solution for Infusion BP PA2299/008/001
Sodium chloride, Glucose
Baxter Holding B.V.
Marketed
Sodium Chloride 0.45% w/v Solution for Infusion PA2299/002/002
Sodium chloride
Baxter Holding B.V.
Marketed
Sodium Chloride 0.9% w/v and Glucose 5% w/v Solution for Infusion BP (Viaflo container) PA2299/008/002
Sodium chloride, Glucose
Baxter Holding B.V.
Marketed
Sodium Chloride 0.9% w/v Intravenous Infusion BP PA2299/002/001
Sodium chloride
Baxter Holding B.V.
Marketed
Sodium Chloride Intravenous Infusion BP 0.9% w/v (viaflex container) PA2299/002/003
Sodium chloride
Baxter Holding B.V.
Marketed
Sugammadex 100 mg/ml Solution for Injection PA2299/058/001
Sugammadex sodium
Baxter Holding B.V.
Not marketed
Suprane Inhalation vapour, solution PA2299/023/001
Desflurane
Baxter Holding B.V.
Marketed
TISSEEL Lyo Powder and Solvent for Sealant PA2299/025/002
Human fibrinogen, Aprotinin, Human thrombin, Human factor xiii, Calcium chloride
Baxter Holding B.V.
Marketed
TISSEEL Ready to use Solutions for Sealant PA2299/025/001
Human fibrinogen, Aprotinin, Human factor xiii, Human thrombin, Calcium chloride
Baxter Holding B.V.
Marketed
Tranexamic acid 100 mg/mL solution for injection/infusion PA2299/048/001
TRANEXAMIC ACID PH. EUR.
Baxter Holding B.V.
Not marketed
TRIOMEL 12 g/l nitrogen 950 kcal/l with electrolytes, emulsion for infusion PA2299/043/007
Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine
Baxter Holding B.V.
Marketed
TRIOMEL 12 g/l nitrogen 950 kcal/l, emulsion for infusion PA2299/043/008
Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine
Baxter Holding B.V.
Marketed
Triomel 5g/L nitrogen 990kcal/L with electrolytes, emulsion for infusion PA2299/029/002
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid
Baxter Holding B.V.
Marketed
Triomel 7g/L nitrogen 1140kcal/L emulsion for infusion PA2299/029/004
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid
Baxter Holding B.V.
Marketed
Triomel 7g/L nitrogen 1140kcal/L with electrolytes emulsion for infusion PA2299/029/003
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid
Baxter Holding B.V.
Marketed
Triomel 9g/L nitrogen 1070kcal/L emulsion for infusion PA2299/029/006
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid
Baxter Holding B.V.
Marketed
Triomel 9g/L nitrogen 1070kcal/L with electrolytes emulsion for infusion PA2299/029/005
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid
Baxter Holding B.V.
Marketed
Triomel Peripheral 4 g/L nitrogen 700 kcal/L with electrolytes emulsion for infusion PA2299/029/001
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid
Baxter Holding B.V.
Marketed
Uromitexan 100mg/ml Solution for Injection or Infusion PA2299/024/001
Mesna
Baxter Holding B.V.
Marketed
Uromitexan tablets 400 mg PA2299/024/002
Mesna
Baxter Holding B.V.
Marketed
Uromitexan Tablets 600mg PA2299/024/003
Mesna
Baxter Holding B.V.
Marketed
Water for Injections Ph. Eur., viaflo container PA2299/013/001
Water for injection
Baxter Holding B.V.
Marketed
Showing 51–84 of 84
Previous 1 2
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 29 September 2026. https://priyalifescience.com/medicines

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.